Chimerix, Inc.

Durham | United States

Лечение | Медикаменты

https://www.chimerix.com/our-science/dstat/

Chimerix, Inc. has developed a heparin-derived blood cancer drug could reduce inflammation and hypercoagulation in COVID-19 patients with acute lung injury (ALI).

Rankings by

Национальный рейтинг

443rd

in United States

Региональный рейтинг

502nd

in North America and Caribbean

Глобальный рейтинг

1217th

worldwide

Loading startups...